The use of 18 F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Glaudemans, Andor W J M ^a   De Vries, Erik F J ^a   Galli, Filippo ^b   Dierckx, Rudi A J O ^a   Slart, Riemer H J A ^a   Signore, Alberto ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; INFLIXIMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AORTA ARCH SYNDROME; ARTICLE; AUTOIMMUNE PANCREATITIS; AUTOIMMUNE THYROIDITIS; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ECHINOCOCCOSIS; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GIANT CELL ARTERITIS; HASHIMOTO DISEASE; HUMAN; INFECTION; INFLAMMATORY DISEASE; INTERVERTEBRAL DISK DEGENERATION; INVASIVE CANDIDIASIS; LUNG PARENCHYMA; MULTICENTER STUDY (TOPIC); MYCOSIS; OSTEOMYELITIS; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ULCERATIVE COLITIS; VASCULITIS; WHOLE BODY IMAGING; COMMUNICABLE DISEASE; INFLAMMATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; COMMUNICABLE DISEASES; DIAGNOSTIC USE;

COMMUNICABLE DISEASES; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884248138     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/623036     Document Type: Article

References (100)

1. Ruf J., Oeser C., Amthauer H., Clinical role of anti-granulocyte MoAb versus radiolabeled white blood cells. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2010 54 6 599 616 2-s2.0-79953108831
2. Signore A., Glaudemans A. W. J. M., The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Annals of Nuclear Medicine 2011 25 10 681 700 2-s2.0-83855165774 10.1007/s12149-011-0521-z
3. Glaudemans A. W. J. M., Signore A., FDG-PET/CT in infections: the imaging method of choice? European Journal of Nuclear Medicine and Molecular Imaging 2010 37 10 1986 1991 2-s2.0-79952112119
4. Arend W. P., Michel B. A., Bloch D. A., Hunder G. G., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y., Lie J. T., Lightfoot R. W. Jr., Masi A. T., McShane D. J., Mills J. A., Stevens M. B., Wallace S. L., Zvaifler N. J., The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis and Rheumatism 1990 33 8 1129 1134 2-s2.0-0025042935
5. Hunder G. G., Bloch D. A., Michel B. A., Stevens M. B., Arend W. P., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y., Lie J. T., Lightfoot R. W. Jr., Masi A. T., McShane D. J., Mills J. A., Wallace S. L., Zvaifler N. J., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis and Rheumatism 1990 33 8 1122 1128 2-s2.0-0025103002
6. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. M., Mccluskey R. T., Sinico R. A., Rees A. J., Van Leendert A. E. S., Waldherr R., Wiik A., Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis and Rheumatism 1994 37 2 187 192 2-s2.0-0028158243
7. Zeek P. M., Periarteritis nodosa; a critical review. American Journal of Clinical Pathology 1952 22 8 777 790 2-s2.0-0000780636
8. Luqmani R. A., Suppiah R., Grayson P. C., Merkel P. A., Watts R., Nomenclature and classification of vasculitis-update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS). Clinical and Experimental Immunology 2011 164 supplement 1 11 13 2-s2.0-79953147890 10.1111/j.1365-2249. 2011.04358.x
9. Bau J. L., Ly J. Q., Borstad G. C., Lusk J. D., Seay T. M., Beall D. P., Giant cell arteritis. American Journal of Roentgenology 2003 181 3 742 2-s2.0-0041508756
10. Bertagna F., Bosio G., Caobelli F., Motta F., Biasiotto G., Giubbini R., Role of 18F-fl uorodeoxyglucose positron emission tomography/computed tomography for therapy evaluation of patients with large-vessel vasculitis. Japanese Journal of Radiology 2010 28 3 199 204 2-s2.0-77954575990 10.1007/s11604-009- 0408-2
11. Beggs A. D., Hain S. F., F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis. Clinical Nuclear Medicine 2002 27 10 705 706 2-s2.0-0036777183 10.1097/00003072-200210000-00004
12. Morita H., Yokoyama I., Yamada N., Uno K., Nagai R., Usefulness of 18FDG/13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome. European Journal of Nuclear Medicine and Molecular Imaging 2004 31 8 1218 2-s2.0-16644398671
13. Yoshibayashi M., Tamaki N., Nishioka K., Matsumura M., Ueda T., Temma S., Yonekura Y., Yamashita K., Konishi J., Mikawa H., Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance. American Journal of Cardiology 1991 68 17 1638 1645 2-s2.0-0026329409 10.1016/0002-9149(91)90322-C
14. Rauh G., Kamilli I., Gresser U., Landthaler M., Relapsing polychondritis presenting as cutaneous polyarteritis nodosa. Clinical Investigator 1993 71 4 305 309 2-s2.0-0027522921
15. Clifford A., Burrell S., Hanly J. G., Positron emission tomography/computed tomography for the diagnosis and assessment of giant cell arteritis: when to consider it and why. The Journal of Rheumatology 2012 39 1909 1911
16. Zerizer I., Tan K., Khan S., Barwick T., Marzola M. C., Rubello D., Al-Nahhas A., Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. European Journal of Radiology 2010 73 3 504 509 2-s2.0-77949654358 10.1016/j.ejrad.2010.01.021
17. Webb M., Chambers A., Al-Nahhas A., Mason J. C., Maudlin L., Rahman L., Frank J., The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. European Journal of Nuclear Medicine and Molecular Imaging 2004 31 5 627 634 2-s2.0-2442618997
18. Bleeker-Rovers C. P., Bredie S. J. H., van der Meer J. W. M., Corstens F. H. M., Oyen W. J. G., F-I8-fluorodeoxyglucose positron emmission tomography in diagnosis and follow-up of patients with different types of vasculitis. Netherlands Journal of Medicine 2003 61 10 323 329 2-s2.0-1442334564
19. Jaruskova M., Belohlavek O., Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. European Journal of Nuclear Medicine and Molecular Imaging 2006 33 8 913 918 2-s2.0-33746450490 10.1007/s00259-006-0064-z
20. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C. O., Lehmann K., Conrad M., Vosshenrich R., Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging 2003 30 5 730 736 2-s2.0-0037907540
21. Walter M. A., Melzer R. A., Schindler C., Müller-Brand J., Tyndall A., Nitzsche E. U., The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. European Journal of Nuclear Medicine and Molecular Imaging 2005 32 6 674 681 2-s2.0-21244483810 10.1007/s00259-004-1757-9
22. Blockmans D., De Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., Bobbaers H., Repetitive18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Care and Research 2006 55 1 131 137 2-s2.0-32544453865 10.1002/art.21699
23. Henes J. C., Müller M., Pfannenberg C., Kanz L., Kötter I., Cyclophosphamide for large-vessel vasculitis: assessment of response by PET/CT. Clinical and Experimental Rheumatology 2011 29 1, supplement 64 S43 S48 2-s2.0-79960434372
24. Fuchs M., Briel M., Daikeler T., Walker U. A., Rasch H., Berg S., Ng Q. K. T., Raatz H., Jayne D., Kötter I., Blockmans D., Cid M. C., Prieto-González S., Lamprecht P., Salvarani C., Karageorgaki Z., Watts R., Luqmani R., Müller-Brand J., Tyndall A., Walter M. A., The impact of18F-FDG PET on the management of patients with suspected large vessel vasculitis. European Journal of Nuclear Medicine and Molecular Imaging 2012 39 2 344 353 2-s2.0-84859628890 10.1007/s00259-011-1967-x
25. Scadding J. G., Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. British Medical Journal 1961 2 1165 1172
26. Nunes H., Brillet P.-Y., Valeyre D., Brauner M. W., Wells A. U., Imaging in sarcoidosis. Seminars in Respiratory and Critical Care Medicine 2007 28 1 102 120 2-s2.0-33847674390 10.1055/s-2007-970336
27. Hansell D. M., High-resolution CT of diffuse lung disease: value and limitations. Radiologic Clinics of North America 2001 39 6 1091 1113 2-s2.0-0034764530 10.1016/S0033-8389(05)70333-X
28. Lee K. S., Primack S. L., Staples C. A., Mayo J. R., Aldrich J. E., Müller N. L., Chronic infiltrative lung disease: comparison of diagnostic accuracies of radiography and low- and conventional-dose thin-section CT. Radiology 1994 191 3 669 673 2-s2.0-23444451272
29. Mana J., Salazar A., Manresa F., Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994 61 4 219 225 2-s2.0-0027954014
30. Takada K., Ina Y., Noda M., Sato T., Yamamoto M., Morishita M., The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. Journal of Clinical Epidemiology 1993 46 4 359 366 2-s2.0-0027298918 10.1016/0895-4356(93)90150-Y
31. Teirstein A. S., Machac J., Almeida O., Lu P., Padilla M. L., Iannuzzi M. C., Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007 132 6 1949 1953 2-s2.0-37549040203 10.1378/chest.07-1178
32. Brancato S. C., Arrighi J. A., Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis. Journal of Nuclear Cardiology 2011 18 2 371 374 2-s2.0-79958080434 10.1007/s12350-011-9347-2
33. Aide N., Benayoun M., Kerrou K., Khalil A., Cadranel J., Talbot J. N., Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy. The British Journal of Radiology 2007 80 951 e67 e71 2-s2.0-34447105913
34. Keijsers R. G., Grutters J. C., Thomeer M., Du Bois R. M., Van Buul M. M., Lavalaye J., Van Den Bosch J. M., Verzijlbergen F. J., Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of67Ga imaging and18F-FDG PET. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2011 55 1 66 71 2-s2.0-79957451426
35. Prager E., Wehrschuetz M., Bisail B., Woltsche M., Schwarz T., Lanz H., Sorantin E., Aigner R. M., Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. NuklearMedizin 2008 47 1 18 23 2-s2.0-39449135258 10.3413/nukmed-0085
36. Keijsers R. G., Grutters J. C., van Velzen-Blad H., van den Bosch J. M., Oyen W. J., Verzijlbergen F. J., 18F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis. European Journal of Nuclear Medicine and Molecular Imaging 2010 37 6 1181 1188 2-s2.0-77954888580 10.1007/s00259-009-1376-6
37. Keijsers R. G., Verzijlbergen F. J., van den Bosch J. M., Zanen P., Van De Garde E. M., Oyen W. J., Grutters J. C., 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2011 28 2 123 129 2-s2.0-81455142049
38. Soussan M., Augier A., Brillet P. Y., Weinmann P., Valeyre D., Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features. Clinical Nuclear Medicine 2013 10.1097/RLU.0b013e318279f264
39. Aide N., Allouache D., Ollivier Y., de Raucourt S., Switsers O., Bardet S., Early 2′-Deoxy-2′-[18F]Fluoro-D-Glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesions. Molecular Imaging and Biology 2009 11 4 224 228 2-s2.0-67649398845 10.1007/s11307-008-0191-y
40. Basu S., Zhuang H., Torigian D. A., Rosenbaum J., Chen W., Alavi A., Functional imaging of inflammatory diseases using nuclear medicine techniques. Seminars in Nuclear Medicine 2009 39 2 124 145 2-s2.0-58849130730 10.1053/j.semnuclmed.2008.10.006
41. Braun J. J., Kessler R., Constantinesco A., Imperiale A., 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 8 1537 1543 2-s2.0-48149084959 10.1007/s00259-008-0770-9
42. Imperiale A., Riehm S., Veillon F., Namer I.-J., Braun J.-J., FDG PET coregistered to MRI for diagnosis and monitoring of therapeutic response in aggressive phenotype of sarcoidosis. European Journal of Nuclear Medicine and Molecular Imaging 2011 38 5 983 984 2-s2.0-79953675670 10.1007/s00259-010-1725-5
43. Keijsers R. G. M., Verzijlbergen J. F., van Diepen D. M., van den Bosch J. M. M., Grutters J. C., 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2008 25 2 143 149 2-s2.0-62549089127
44. Hashefi M., Curiel R., Future and upcoming non-neoplastic applications of PET/CT imaging. Annals of the New York Academy of Sciences 2011 1228 1 167 174 2-s2.0-79959806722 10.1111/j.1749-6632.2011.06082.x
45. Kubota K., Ito K., Morooka M., Mitsumoto T., Kurihara K., Yamashita H., Takahashi Y., Mimori A., Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Annals of Nuclear Medicine 2009 23 9 783 791 2-s2.0-73449142102 10.1007/s12149-009-0305-x
46. McBride H. J., Nuclear imaging of autoimmunity: focus on IBD and RA. Autoimmunity 2010 43 7 539 549 2-s2.0-77957980588 10.3109/08916931003674766
47. Kubota K., Ito K., Morooka M., Minamimoto R., Miyata Y., Yamashita H., Takahashi Y., Mimori A., FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. Annals of the New York Academy of Sciences 2011 1228 1 29 38 2-s2.0-79959805079 10.1111/j.1749-6632.2011.06031.x
48. Palmer W. E., Rosenthal D. I., Schoenberg O. I., Fischman A. J., Simon L. S., Rubin R. H., Polisson R. P., Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and pet with 2-[F-18]-fluoro-2-deoxy-D- glucose. Radiology 1995 196 3 647 655 2-s2.0-0029128220
49. Beckers C., Ribbens C., André B., Marcelis S., Kaye O., Mathy L., Kaiser M.-J., Hustinx R., Foidart J., Malaise M. G., Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine 2004 45 6 956 964 2-s2.0-3242661962
50. Goerres G. W., Forster A., Uebelhart D., Seifert B., Treyer V., Michel B., Von Schulthess G. K., Kaim A. H., F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clinical Nuclear Medicine 2006 31 7 386 390 2-s2.0-33748149450 10.1097/01.rlu.0000222678.95218.42
51. Elzinga E. H., van der Laken C. J., Comans E. F. I., Boellaard R., Hoekstra O. S., Dijkmans B. A. C., Lammertsma A. A., Voskuyl A. E., 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. Journal of Nuclear Medicine 2011 52 1 77 80 2-s2.0-79851499258 10.2967/jnumed.110.076711
52. Colebatch A. N., Edwards C. J., Ostergaard M., EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Annals of the Rheumatic Diseases 2013 72 6 804 814 10.1136/annrheumdis-2012-203158
53. Chandler M. B., Zeddun S. M., Borum M. L., The role of positron emission tomography in the evaluation of inflammatory bowel disease. Annals of the New York Academy of Sciences 2011 1228 1 59 63 2-s2.0-79959772754 10.1111/j.1749-6632.2011.06032.x
54. Glaudemans A. W. J. M., Maccioni F., Mansi L., Dierckx R. A. J. O., Signore A., Imaging of cell trafficking in Crohn's disease. Journal of Cellular Physiology 2010 223 3 562 571 2-s2.0-77951218090 10.1002/jcp.22069
55. de Bie C. I., Buderus S., Sandhu B. K., De Ridder L., Paerregaard A., Veres G., Dias J. A., Escher J. C., Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: results of a 5-year audit of the EUROKIDS registry. Journal of Pediatric Gastroenterology and Nutrition 2012 54 3 374 380 2-s2.0-84857791004 10.1097/MPG.0b013e318231d984
56. Sauer C. G., Kugathasan S., Martin D. R., Applegate K. E., Medical radiation exposure in children with inflammatory bowel disease estimates high cumulative doses. Inflammatory Bowel Diseases 2011 17 11 2326 2332 2-s2.0-80054745053 10.1002/ibd.21626
57. Däbritz J., Jasper N., Loeffler M., Weckesser M., Foell D., Noninvasive assessment of pediatric inflammatory bowel disease with 18F-fluorodeoxyglucose-positron emission tomography and computed tomography. European Journal of Gastroenterology and Hepatology 2011 23 1 81 89 2-s2.0-78650766318 10.1097/MEG.0b013e3283410222
58. Löffler M., Weckesser M., Franzius C., Schober O., Zimmer K.-P., High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Annals of the New York Academy of Sciences 2006 1072 379 385 2-s2.0-33749016032 10.1196/annals.1326.014
59. Lapp R. T., Spier B. J., Perlman S. B., Jaskowiak C. J., Reichelderfer M., Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Molecular Imaging and Biology 2011 13 3 573 576 2-s2.0-79956223050 10.1007/s11307-010-0367-0
60. Das C. J., Makharia G. K., Kumar R., Kumar R., Tiwari R. P., Sharma R., Malhotra A., PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis. European Journal of Nuclear Medicine and Molecular Imaging 2010 37 4 714 721 2-s2.0-77952092772 10.1007/s00259-009-1335-2
61. Spier B. J., Perlman S. B., Jaskowiak C. J., Reichelderfer M., PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Molecular Imaging and Biology 2010 12 1 85 88 2-s2.0-77149138854 10.1007/s11307-009-0232-1
62. Treglia G., Quartuccio N., Sadeghi R., Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis. Journal of Crohn's and Colitis 2013 7 345 354
63. Karantanis D., Bogsrud T. V., Wiseman G. A., Mullan B. P., Subramaniam R. M., Nathan M. A., Peller P. J., Bahn R. S., Lowe V. J., Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. Journal of Nuclear Medicine 2007 48 6 896 901 2-s2.0-34250360184 10.2967/jnumed.106.039024
64. Slman R., Monpeyssen H., Desarnaud S., Haroche J., Fediaevsky L. D. P., Fabrice M., Seret-Begue D., Amoura Z., Aurengo A., Leenhardt L., Ultrasound, elastography, and fluorodeoxyglucose positron emission tomography/computed tomography imaging in riedel's thyroiditis: report of two cases. Thyroid 2011 21 7 799 804 2-s2.0-79959817829 10.1089/thy.2010.0242
65. Song Y. S., Jang S. J., Chung J.-K., Lee D. S., F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnate scan findings of a patient with unilateral subacute thyroiditis. Clinical Nuclear Medicine 2009 34 7 456 458 2-s2.0-67650647160 10.1097/RLU.0b013e3181a7d24a
66. Yeo S. H., Lee S. K., Hwang I., Ahn E. J., Subacute thyroiditis presenting as a focal lesion on [18F] fluorodeoxyglucose whole-body positron-emission tomography/CT. American Journal of Neuroradiology 2011 32 4 E58 E60 2-s2.0-79954506027 10.3174/ajnr.A2017
67. Rothman I. N., Middleton L., Stack B. C. Jr., Bartel T., Riggs A. T., Bodenner D. L., Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism. European Archives of Oto-Rhino-Laryngology 2011 268 10 1501 1504 2-s2.0-80052767387 10.1007/s00405-011-1512-3
68. Kotilainen P., Airas L., Kojo T., Kurki T., Kataja K., Minn H., Nuutila P., Positron emission tomography as an aid in the diagnosis and follow-up of Riedel's thyroiditis. European Journal of Internal Medicine 2004 15 3 186 189 2-s2.0-3142526434 10.1016/j.ejim.2004.03.002
69. Okazaki K., Uchida K., Fukui T., Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. Journal of Gastroenterology 2008 43 6 409 418 2-s2.0-47349104313 10.1007/s00535-008-2190-9
70. Kamisawa T., Takum K., Anjiki H., Egawa N., Kurata M., Honda G., Tsuruta K., FDG-PET/CT findings of autoimmune pancreatitis. Hepato-Gastroenterology 2010 57 99-100 447 450 2-s2.0-77955485104
71. Matsubayashi H., Furukawa H., Maeda A., Matsunaga K., Kanemoto H., Uesaka K., Fukutomi A., Ono H., Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 2009 9 5 694 699 2-s2.0-68549128777 10.1159/000199439
72. Nakajo M., Jinnouchi S., Fukukura Y., Tanabe H., Tateno R., Nakajo M., The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. European Journal of Nuclear Medicine and Molecular Imaging 2007 34 12 2088 2095 2-s2.0-36749082798 10.1007/s00259-007-0562-7
73. Nakajo M., Jinnouchi S., Noguchi M., Uozumi K., Tanabe H., Tateno R., Nakajo M., FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Clinical Nuclear Medicine 2007 32 4 282 285 2-s2.0-34147111421 10.1097/01.rlu.0000257295.12017.ab
74. Buchs N. C., Bühler L., Bucher P., Willi J.-P., Frossard J.-L., Roth A. D., Addeo P., Rosset A., Terraz S., Becker C. D., Ratib O., Morel P., Value of contrast-enhanced18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study. Journal of Gastroenterology and Hepatology 2011 26 4 657 662 2-s2.0-79952860341 10.1111/j.1440-1746.2010.06525.x
75. Lee S. M., Kim T.-S., Lee J. W., Kim S.-K., Park S.-J., Han S.-S., Improved prognostic value of standardized uptake value corrected for blood glucose level in pancreatic cancer using F-18 FDG PET. Clinical Nuclear Medicine 2011 36 5 331 336 2-s2.0-79955057983 10.1097/RLU.0b013e31820a9eea
76. Tae Y. L., Kim M.-H., Do H. P., Dong W. S., Sung K. L., Jae S. K., Kyu T. L., Utility of18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. American Journal of Roentgenology 2009 193 2 343 348 2-s2.0-68149099591 10.2214/AJR.08.2297
77. Shigekawa M., Yamao K., Sawaki A., Hara K., Takagi T., Bhatia V., Nishio M., Tamaki T., El-Amin H., El-Abdeen Z., Sayed A., Mizuno N., Is18F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? Journal of Hepato-Biliary-Pancreatic Sciences 2010 17 3 269 274 2-s2.0-77955887275 10.1007/s00534-009-0172-9
78. Concia E., Prandini N., Massari L., Ghisellini F., Consoli V., Menichetti F., Lazzeri E., Osteomyelitis: clinical update for practical guidelines. Nuclear Medicine Communications 2006 27 8 645 660 2-s2.0-33748113945 10.1097/00006231-200608000-00007
79. Gotthardt M., Bleeker-Rovers C. P., Boerman O. C., Oyen W. J. G., Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. Journal of Nuclear Medicine 2010 51 12 1937 1949 2-s2.0-78651272044 10.2967/jnumed.110.076232
80. Gratz S., Dörner J., Fischer U., Behr T. M., Béhé M., Altenvoerde G., Meller J., Grabbe E., Becker W., 18F-FDG hybrid PET in patients with suspected spondylitis. European Journal of Nuclear Medicine 2002 29 4 516 524 2-s2.0-0036202038 10.1007/s00259-001-0719-8
81. Wang G.-L., Zhao K., Liu Z.-F., Dong M.-J., Yang S.-Y., A meta-analysis of fluorodeoxyglucose-positron emission tomography versus scintigraphy in the evaluation of suspected osteomyelitis. Nuclear Medicine Communications 2011 32 12 1134 1142 2-s2.0-80455122934 10.1097/MNM.0b013e32834b455c
82. Darge K., Jaramillo D., Siegel M. J., Whole-body MRI in children: current status and future applications. European Journal of Radiology 2008 68 2 289 298 2-s2.0-54149120227 10.1016/j.ejrad.2008.05.018
83. Ito K., Kubota K., Morooka M., Hasuo K., Kuroki H., Mimori A., Clinical impact of 18F-FDG PET/CT on the management and diagnosis of infectious spondylitis. Nuclear Medicine Communications 2010 31 8 691 698 2-s2.0-77954243678 10.1097/MNM.0b013e32833bb25d
84. Gemmel F., Rijk P. C., Collins J. M. P., Parlevliet T., Stumpe K. D., Palestro C. J., Expanding role of 18F-fluoro-d-deoxyglucose PET and PET/CT in spinal infections. European Spine Journal 2010 19 4 540 551 2-s2.0-77951106542 10.1007/s00586-009-1251-y
85. Warmann S. W., Dittmann H., Seitz G., Bares R., Fuchs J., Schäfer J. F., Follow-up of acute osteomyelitis in children: the possible role of PET/CT in selected cases. Journal of Pediatric Surgery 2011 46 8 1550 1556 2-s2.0-80051866189 10.1016/j.jpedsurg.2010.11.037
86. Leone S., Borrè S., Monforte A. D., Mordente G., Petrosillo N., Signore A., Venditti M., Viale P., Nicastri E., Lauria F. N., Carosi G., Moroni M., Ippolito G., Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. International Journal of Infectious Diseases 2010 14 supplement 4 S67 S77 2-s2.0-78149279830 10.1016/j.ijid.2010.05. 005
87. Jones-Jackson L., Walker R., Purnell G., McLaren S. G., Skinner R. A., Thomas J. R., Suva L. J., Anaissie E., Miceli M., Nelson C. L., Ferris E. J., Smeltzer M. S., Early detection of bone infection and differentiation from post-surgical inflammation using 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography (FDG-PET) in an animal model. Journal of Orthopaedic Research 2005 23 6 1484 1489 2-s2.0-27644580399 10.1016/j.orthres.2005.03.010
88. Familiari D., Glaudemans A. W. J. M., Vitale V., Prosperi D., Bagni O., Lenza A., Cavallini M., Scopinaro F., Signore A., Can sequential18F-FDG PET/CT replace WBC imaging in the diabetic foot? Journal of Nuclear Medicine 2011 52 7 1012 1019 2-s2.0-79960292948 10.2967/jnumed.110.082222
89. Jamar F., Buscombe J., Chiti A., EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. Journal of Nuclear Medicine 2013 54 647 658
90. Bleeker-Rovers C. P., Warris A., Drenth J. P. H., Corstens F. H. M., Oyen W. J. G., Kullberg B.-J., Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clinical Microbiology and Infection 2005 11 6 493 495 2-s2.0-19744376093 10.1111/j.1469-0691.2005.01155.x
91. Huang C.-J., You D.-L., Lee P.-I., Hsu L.-H., Liu C.-C., Shih C.-S., Shih C.-C., Tseng H.-C., Characteristics of integrated18F-FDG PET/CT in pulmonary cryptococcosis. Acta Radiologica 2009 50 4 374 378 2-s2.0-67651235477 10.1080/02841850902756532
92. Igai H., Gotoh M., Yokomise H., Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-d-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer. European Journal of Cardio-Thoracic Surgery 2006 30 6 837 839 2-s2.0-33750937389 10.1016/j.ejcts.2006.09.022
93. Kobayashi E., Iwamiya T., Masaki H., Yamagata A., Isobe M., Miyake T., Shiki Y., Nakashima R., Yamasaki M., Postoperative abdominal aspergilloma mimicking cervical cancer recurrence and diagnostic imaging, including18F-fluorodeoxyglucose positron emission tomography, with false-positive findings. Journal of Obstetrics and Gynaecology Research 2009 35 4 808 811 2-s2.0-70049104899 10.1111/j.1447-0756.2009.01019.x
94. Salhab K. F., Baram D., Bilfinger T. V., Growing PET positive nodule in a patient with histoplasmosis: case report. Journal of Cardiothoracic Surgery 2006 1 1, article 23 2-s2.0-34248384447 10.1186/1749-8090-1-23
95. Sojan S. M., Chew G., Pneumocystis carinii Pneumonia on F-18 FDG PET. Clinical Nuclear Medicine 2005 30 11 763 764 2-s2.0-27644508731 10.1097/01.rlu.0000182281.69764.41
96. Teyton P., Baillet G., Hindié E., Filmont J. E., Sarandi F., Toubert M.-E., Moretti J. L., Hepatosplenic candidiasis imaged with F-18 FDG PET/CT. Clinical Nuclear Medicine 2009 34 7 439 440 2-s2.0-67650630945 10.1097/RLU.0b013e3181a7cfba
97. Chamilos G., Macapinlac H. A., Kontoyiannis D. P., The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Medical Mycology 2008 46 1 23 29 2-s2.0-39749094380 10.1080/13693780701639546
98. Basu S., Saboury B., Werner T., Alavi A., Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders. Molecular Imaging and Biology 2011 13 6 1051 1060 2-s2.0-84855658249 10.1007/s11307-010-0459-x
99. Franzius C., Biermann M., HüLskamp G., Frosch M., Roth J., Sciuk J., Schober O., Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clinical Nuclear Medicine 2001 26 3 232 233 2-s2.0-0035115877 10.1097/00003072-200103000-00011
100. Xu B., Shi P., Wu H., Guo X., Wang Q., Zhou S., Utility of FDG PET/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis. Clinical Nuclear Medicine 2010 35 8 567 570 2-s2.0-77955130784 10.1097/RLU.0b013e3181e4db84